Newly Diagnosed With Ovarian Cancer? Ask for Help and Get Educated, Says One Patient

Video

Diane Powis spent more than 10 months bouncing from one doctor to the next before finally being “blindsided by” a diagnosis of stage 3 ovarian cancer. But as her initial feelings of isolation and fear wore off, Powis soon learned that she wasn’t alone – and that help and information were out there.

Diane Powis spent more than 10 months bouncing from one doctor to the next before finally being “blindsided by” a diagnosis of stage 3 ovarian cancer. But as her initial feelings of isolation and fear wore off, Powis soon learned that she wasn’t alone – and that help and information were out there.

In an interview with CURE®, Powis recently opened up about how her diagnosis taught her to ask for help, and how finding a community of fellow patients helped her realize that “knowledge is power.”

“I've learned a lot about being open,” Powis said. “And it's funny where help comes from, the places you don't expect.”

Transcription
First of all, ask for help. And I think as women, it's so hard. I think so many of us are caretakers, and we're used to being there for others, whether it be our family or friends … work, but, you need it. And I've learned a lot about being open. And it's funny where help comes from, the places you don't expect. Sometimes you get a lot of help.

I would also say, to reach out to others with the disease; it can be very helpful, I think. I felt so alone, initially, like I was the only person in the world who's dealing with this. But that is so not true. There's over 200,000 women, closer to three (hundred thousand), living with ovarian cancer right now. And there are so many organizations out there that you can connect with, support groups, or to get information (from), because I really, I feel like knowledge is power in all of this, that you really need to educate yourself.

And you know, I think there's a lot of misinformation out there. So, if you look around a little bit, you can get connected to these organizations and this information. It exists. So those are some of the things I would recommend.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE
Dr. Giles in an interview with CURE